 More than half of cardiovascular patients who could benefit from aspirin for secondary prevention were not prescribed the drug researchers found Aspirin or other antiplatelet drugs were prescribed for secondary prevention in only  percent of outpatient visits in  a rate virtually unchanged from the  period according to Anand K Parekh MD MPH from the US Department of Health and Human Services and colleagues Also in  general medicine or primary care physicians prescribed antiplatelet medications to cardiovascular patients only  percent of the time a decrease from  percent in  they wrote in a perspective article published in the Jan  issue of the  These data from the National Ambulatory Medical Care Survey and National Hospital Ambulatory Medical Care Survey of the CDC are sobering in light of the evidence that aspirin can reduce recurrent major cardiovascular events such as stroke heart attack or peripheral arterial disease the researchers wrote Everyone without a contraindication should receive aspirin they said The investigators pegged the number of US adults at risk for a recurrent cardiovascular event at about  million of whom most could benefit from an aspirin regimen With a staggering annual cost to the US of  billion cardiovascular events can be held at bay simply by utilizing an inexpensive overthecounter drug that needs to be taken only once a day Parekh and colleagues wrote The use of aspirin couldnt be more straightforward they said as it requires no screening no laboratory tests to outline a therapeutic course and no specific behavioral changes Suboptimal prescribing can be bolstered by technology Parekh and colleagues said by including aspirin reminders in electronic health record systems The authors listed incentive programs to help increase evidencebased prescribing The Physician Quality Reporting System for example will award physicians a  percent incentive payment for reporting quality measures that include aspirin use In addition payforreporting and subsequent payforperformance incentives for accountable care organizations will kick in under the Affordable Care Act and quality measures include aspirin use for various patients such as those with ischemic vascular disease National awareness programs have been launched as well including the American Heart Associations AHA   the goal of which is to focus coordinate and enhance activities for cardiovascular disease prevention across the public and private sectors in an effort to prevent one million heart attacks and strokes by  the authors wrote Other national programs such as the AHAs Get with the Guidelines and the CDCs Paul Coverdell National Acute Stroke Program set the standard for aspirin to be prescribed at discharge In addition many practices track performance measures such as adherence to evidencebased guidelines including aspirin therapy for secondary prevention Parekh and colleagues said Outreach efforts need to be made to educate clinicians about initiatives programs registries and technological solutions geared toward improving the use of aspirin to reduce the risk of cardiovascular events they said There is an important and urgent opportunity to engage all healthcare providers particularly primary care providers in a singular simple intervention with the potential to prevent heart attacks and strokes and save lives they concluded Source 